I am new to this forum. It seems like an amazing support community.
My dad is 72, PSA is rising after radiation treatment and hormone therapy for the past 2 years. He has now become castrate resistant and mets on bones in his pelvic area, arm, spine and neck.
He has the following options.
1) Abiraterone with denosumab and prednisone
2) Join a clinical trial which combines the above along with immunotheraphy (pembrolizumab). I've read some papers, and while some have experienced very positive benefits, these seems overall, there is not much benefit.
3) Last option is to see if his cancer is genetic. If so, he will qualify for a trial that combines option 1 with a PARP inhibitor (Niraparib). However, we have to wait a couple of weeks for the results of this test to see if he qualifies. Also, half the patients will receive a placebo.
I just wanted to hear some feedback if anyone has used PARP inhibitors and if its worth the wait.
Written by
ArabianNights
To view profiles and participate in discussions please or .
Start with a genomic test of a biopsy from one of his larger mets. That will tell him if he are likely to respond to pembro (MSI-hi/dMMR), or a PARP inhibitor (if BRCA1/2 mutant).
You didn't list chemo or Xofigo among the options - why?
Is he seeing an oncologist at a top cancer center? He may have some comorbiditythat precludes chemo, otherwise it should be considered as should Xofigo.
His PSA has more than doubled in a month. It went from 1 to 2.7 in 6 weeks.
I wonder if it is worth to wait another 3 weeks to get the results and another 3 to be considered for a trial (6 or more weeks). Or should he start the Abiraterone right away? Doctors won’t have him join the clinical trial if he begins with Abiraterone now.
My principal: always let your medical self-interest preempt issues around procedures related to clinical trials, Especially those that could result in a placebo. Start the Abiraterone.
After several Guardant360 liquid biopsies over the years, my cancer had an ATM defect which qualified me for the PARP inhibitor Lynparza.
Lynparza worked for about 9 months before cancer found a workaround. Do not recall any serious SEs. Lynparza can be expensive so check your Dad’s coverage if he goes forward.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.